40.62
Schlusskurs vom Vortag:
$40.81
Offen:
$41.15
24-Stunden-Volumen:
201.38K
Relative Volume:
0.41
Marktkapitalisierung:
$2.02B
Einnahmen:
$499.95M
Nettoeinkommen (Verlust:
$-36.36M
KGV:
-52.75
EPS:
-0.77
Netto-Cashflow:
$24.22M
1W Leistung:
-1.91%
1M Leistung:
+22.50%
6M Leistung:
+28.50%
1J Leistung:
+34.28%
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Vergleichen Sie ATRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ATRC
Atricure Inc
|
40.65 | 2.03B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
563.41 | 197.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
194.66 | 55.76B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.76 | 38.93B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
242.35 | 35.90B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
268.81 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference - BioSpace
Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way? - 富途牛牛
JPMorgan Chase & Co. Boosts AtriCure (NASDAQ:ATRC) Price Target to $48.00 - MarketBeat
JP Morgan Raises AtriCure (ATRC) Price Target to $48 | ATRC Stoc - GuruFocus
AtriCure price target raised to $48 from $42 at JPMorgan - TipRanks
AtriCure, Inc. $ATRC Shares Acquired by Squarepoint Ops LLC - MarketBeat
AtriCure (ATRC) Is Up 6.3% After First Dual-Energy PFA–RFA Human Procedures Success - Sahm
AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human SuccessHas The Bull Case Changed? - Yahoo Finance
Loss Report: What valuation multiples suggest for AtriCure Inc stockJuly 2025 Outlook & Fast Entry Momentum Alerts - moha.gov.vn
AtriCure treats first patients with dual PFA/RF system - MedTech Dive
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform - Finviz
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year? - MSN
AtriCure reports first patients treated with dual-energy PFA, RF platform - MassDevice
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform - 01net
AtriCure, Inc. Announces the First Patients Treated with Novel Dual Energy Platform - marketscreener.com
AtriCure Reports 1st Treatments with Dual Energy RF, PFA System - Medical Product Outsourcing
AtriCure Says First Patients Treated With Dual-Energy Platform - marketscreener.com
AtriCure (ATRC) Introduces Cutting-Edge Dual Energy Platform in Initial Treatments - GuruFocus
AtriCure, Inc.'s (NASDAQ:ATRC) 29% Share Price Surge Not Quite Adding Up - simplywall.st
Russell Investments Group Ltd. Decreases Stake in AtriCure, Inc. $ATRC - MarketBeat
Are Medical Stocks Lagging AtriCure (ATRC) This Year? - Yahoo Finance
Hood River Capital Management LLC Has $100.31 Million Holdings in AtriCure, Inc. $ATRC - MarketBeat
Will AtriCure Inc. stock deliver strong dividend growthPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Why analysts remain bullish on AtriCure Inc. stock2025 Trading Recap & Consistent Growth Stock Picks - Newser
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? - AOL.com
AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance - MSN
Geode Capital Management LLC Purchases 14,577 Shares of AtriCure, Inc. $ATRC - MarketBeat
How supply chain issues affect AtriCure Inc. stockJuly 2025 Volume & Scalable Portfolio Growth Methods - BỘ NỘI VỤ
Insider Selling: AtriCure (NASDAQ:ATRC) Director Sells 4,967 Shares of Stock - MarketBeat
Atricure Executives Make Significant Stock Sales - TipRanks
Insider Sell: Justin Noznesky Sells 5,166 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure Executives Engage in Stock Transactions - TradingView
Atricure Insider Sold Shares Worth $376,578, According to a Recent SEC Filing - MarketScreener
Dir Wehrwein Sells 10,000 ($376.6K) Of AtriCure Inc [ATRC] - TradingView
Officer Noznesky Sells 5,166 ($192.6K) Of AtriCure Inc [ATRC] - TradingView
ATRC Form 4: Director exercises $19.95 options, trims holdings - Stock Titan
[Form 4] AtriCure, Inc. Insider Trading Activity - Stock Titan
Precision Trading with Atricure Inc. (ATRC) Risk Zones - news.stocktradersdaily.com
Officer Noznesky Files To Sell 5,166 Of AtriCure Inc [ATRC] - TradingView
Atricure Director Makes a Significant Stock Sale! - TipRanks
AtriCure director Yuen sells $107k in shares By Investing.com - Investing.com Australia
Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade - Finviz
Insider Sell: Maggie Yuen Sells 3,000 Shares of AtriCure Inc (AT - GuruFocus
AtriCure director Yuen sells $107k in shares - Investing.com
AtriCure Director Maggie Yuen Sells 3,000 Shares - TradingView
Dir Wehrwein Files To Sell 5,033 Of AtriCure Inc [ATRC] - TradingView
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):